Across
- 3. Life-threatening condition caused by excess serotonergic activity, characterized by autonomic instability, hyperreflexia, and altered mental status.
- 6. Late-onset involuntary choreoathetoid movements caused by long-term dopamine D2 receptor blockade
- 14. Neonatal bilirubin encephalopathy risk linked to ceftriaxone.
- 17. Term describing the adverse effect of muscarinic blockade causing dry mouth, blurred vision, and confusion.
- 18. Extrapyramidal side effect presenting with resting tremor, rigidity, and slowed movements due to dopamine blockade.
- 19. Neurotransmitter most implicated in reward, psychosis, and movement disorders.
- 20. Neurological movement disorder causing involuntary sustained muscle contractions and facial grimacing.
Down
- 1. Inability to remain still, often caused by medications characterized by fidgeting, pacing, rocking, or foot tapping, leading to significant anxiety and restlessness.
- 2. Negative symptom of schizophrenia involving reduced emotional expression.
- 4. Seven-item scale used to screen and assess severity of generalized anxiety disorder.
- 5. Endocrine side effect most associated with risperidone and paliperidone.
- 7. Rare but life-threatening dermatologic reaction often linked to antiepileptics, sulfa drugs, or lamotrigine; involves mucosal blistering.
- 8. Describes a patient with diminished motivation and indifference to surroundings.
- 9. Add on behaviors or experiences such as hallucinations and delusion not present in a normal healthy person.
- 10. A reduction or absence of normal behaviors, emotions and drives.
- 11. Core symptom of major depressive disorder defined as loss of interest or inability to experience pleasure.
- 12. A hallmark of Bipolar II
- 13. Bipolar mood episode marked by elevated or irritable mood, decreased need for sleep, grandiosity, and impaired functioning for at least 1 week.
- 15. Persistent pattern of excessive worry lasting at least 6 months.
- 16. Nine-item screening tool used to assess severity of depression.